Simplifying Global Compliance
ASPREVA PHARMACEUTICALS APPOINTS WILLIAM L. HUNTER, CEO OF ANGIOTECH PHARMACEUTICALS, TO ITS BOARD OF DIRECTORS
Aspreva Pharmaceuticals Corporation, an emerging pharmaceutical company focused
on increasing the pool of evidence-based medicines available for patients living
with less common diseases, today announced that William Hunter, MD, MSc has
been appointed to the Company's Board of Directors.
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing